Candida auris in China

Abstract

Abstract:

Since it was reported in 2009, Candida auris has been spreading globally, which is a serious threat to human health and attracting the international attention. Recently, two Chinese teams reported Candida auris infection cases, opening the door of Candida auris clinical research in China. Here, we analyzed the current status of Candida auris infection in China and try to put forward the reasonable suggestions and strategies to provide useful information for clinicians.

Key words: Candida auris, multiple drug resistance, China

CLC Number:

R379.4

LIANG Guan-zhao, WU Shao-xi, GUO Ning-ru, LIU Wei-da. Candida auris in China[J]. Chinese Journal of Mycology, 2018, 13(5): 301-304.

References

[1] Satoh K, Makimura K, Hasumi Y, et al. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital[J]. Microbiol Immunol,2009,53(1):41-44.
[2] Navalkele BD, Revankar S, Chandrasekar P. Candida auris:a worrisome, globally emerging pathogen[J]. Expert Rev Anti Infect Ther,2017,15(9):819-827.
[3] Chowdhary A, Sharma C, Meis JF. Candida auris:A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally[J]. PLoS Pathog,2017,13(5):e1006290.
[4] 廖万清,张超,潘炜华. 警惕"超级真菌"感染在中国的出现[J]. 中国真菌学杂志,2017(1):1-2, 7.
[5] 雷岩,张超,潘炜华,等. 耳道念珠菌感染现状与研究进展[J]. 中国真菌学杂志,2018(1):53-56.
[6] Wang X, Bing J, Zheng Q, et al. The first isolate of Candida auris in China:clinical and biological aspects[J]. Emerg Microbes Infect,2018,7(1):93.
[7] Tian S, Rong C, Nian H, et al. First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China[J]. Emerg Microbes Infect,2018,7(1):128.
[8] Sarma S, Upadhyay S. Current perspective on emergence, diagnosis and drug resistance in Candida auris[J]. Infect Drug Resist,2017,10:155-165.
[9] Trofa D, Gacser A, Nosanchuk J D. Candida parapsilosis, an emerging fungal pathogen[J]. Clin Microbiol Rev,2008,21(4):606-625.
[10] Ku T, Walraven CJ, Lee SA. Candida auris:disinfectants and implications for infection control[J]. Front Microbiol,2018,9:726.
[11] Tan YE, Tan AL. Arrival of Candida auris fungus in Singapore:report of the first 3 cases[J]. Ann Acad Med Singapore,2018,47(7):260-262.
[12] Pekard-Amenitsch S, Schriebl A, Posawetz W, et al. Isolation of Candida auris from ear of otherwise healthy patient, Austria, 2018[J]. Emerg Infect Dis,2018,24(8):1596-1597.
[13] Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses[J]. Clin Infect Dis,2017,64(2):134-140.
[14] Bao JR, Master RN, Azad KN, et al. Rapid, accurate identification of Candida auris by using a novel matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) database (Library)[J]. J Clin Microbiol,2018,56(4):e01700-17.
[15] Leach L, Zhu Y, Chaturvedi S. Development and validation of a real-time PCR assay for rapid detection of Candida auris from surveillance samples[J]. J Clin Microbiol,2018,56(2):e01223-17.
[16] Durante AJ, Maloney MH, Leung VH, et al. Challenges in identifying Candida auris in hospital clinical laboratories:a need for hospital and public health laboratory collaboration in rapid identification of an emerging pathogen[J]. Infect Control Hosp Epidemiol,2018,39(8):1015-1016.
[17] Tsay S, Kallen A, Jackson BR, et al. Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast[J]. Clin Infect Dis,2018,66(2):306-311.
[18] Sharma C, Kumar N, Pandey R, et al. Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation[J]. New Microbes New Infect,2016,13:77-82.
[19] Berkow EL, Angulo D, Lockhart SR. In vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical isolates of Candida auris[J]. Antimicrob Agents Chemother,2017,61(7):e00435-17.
[20] Berkow EL, Lockhart SR. Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris[J]. Diagn Microbiol Infect Dis,2018,90(3):196-197.